Suggestions
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania - @BLLPHD
Bruce Levine is a prominent figure in the field of cancer gene therapy and cellular immunotherapy. Here are the key details about his background and current roles:
Professional Positions
Dr. Bruce Levine currently holds several important positions:
- Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania since 199914
- Founding Director of the Clinical Cell and Vaccine Production Facility at the University of Pennsylvania since 199914
- Member of the Board of Directors at Alliance for Cancer Gene Therapy (recently started in 2024)56
Academic and Research Background
Dr. Levine has an extensive academic background:
- Received a B.A. in Biology from the University of Pennsylvania
- Earned a Ph.D. in Immunology and Infectious Diseases from Johns Hopkins University1
Achievements and Contributions
Dr. Levine has made significant contributions to the field of cancer gene therapy:
- Co-inventor of Kymriah, the first FDA-approved gene therapy for leukemia and lymphoma12
- Holds 31 issued US patents and has co-authored over 200 manuscripts and book chapters1
- Has a Google Scholar citation h-index of 108, indicating high impact in his field1
Leadership Roles
In addition to his academic positions, Dr. Levine has taken on various leadership roles:
- Co-founder of Tmunity Therapeutics and Capstan Therapeutics, both spinouts from the University of Pennsylvania14
- Immediate Past-President of the International Society for Cell and Gene Therapy1
- Serves on advisory boards for many companies in the gene therapy space3
Awards and Recognition
Dr. Levine has received numerous awards for his work, including:
- William Osler Patient Oriented Research Award
- Wallace H. Coulter Award for Healthcare Innovation
- American Society for Gene and Cell Therapy Jerry Mendell Award for Translational Science1
Bruce Levine's expertise spans both academic research and industry applications, making him a key figure in advancing cancer gene therapy and cellular immunotherapies.
Highlights
That's bloomin crazy
When lives and trust are on the line, cherry picking evidence or opaque leadership aren’t just policy mistakes — they undermine public health itself. Americans deserve independent expert oversight and transparent decision-making. #FDA
